Please be aware of the following notice
and opportunity to join a VA clinical trials listserv. The listserv
ONCOLOGY-POC-L@WWW.LISTSERV.VA.GOV
may be found on the second page of VA listservs found at
http://www.listserv.va.gov/. I
believe some NPCs have experienced the problem discussed in paragraph
three which identifies a resource for solutions.
Many thanks to Ron Flink, contracts
manager at CARES in Hines, IL, for forwarding this email to the NAVREF
office.
From: Oncology Point of Contact List
[mailto:ONCOLOGY-POC-L@WWW.LISTSERV.VA.GOV]
On Behalf Of Kelley, Michael DURVAMC
Sent: Tuesday, May 18, 2010 4:20 PM
To: ONCOLOGY-POC-L@WWW.LISTSERV.VA.GOV
Subject: Cancer Clinical Trials
Dear Oncology Colleagues,
One of the most common topics I am asked
about is that of access to clinical trials for our veterans with
cancer. Many of you are continuing valiant efforts to provide this
access despite the significant challenges in doing so. I wanted to let
you know of several efforts ongoing at the national level in this
regard.
Some time ago, there was an Interagency
Agreement between the NCI and VA regarding clinical trials, which
expired some time back. Both agencies have continued to honor most if
not all of the provisions of that agreement. That agreement is being
revised and hopefully will be approved later this year.
Some facilities were experiencing
difficulties with local Privacy Officers not approving participation in
NCI sponsored cooperative group studies. Ralph Paxton and others in
Office of Research and Development have worked with NCI to resolve this
issue. Essentially, the VA cannot disapprove of patient-consented
distribution of their person health information. However, again today I
have heard of another facility that appears to be experiencing this
problem. Please bring any such problems to the attention of Dr. Paxton
and myself.
Another expired document relevant to
cancer clinical trials is the National Cancer Strategy directive.
Revisions to that directive have been long delayed due to discussions
about changes relating specifically to clinical trials. Continuing
efforts are being made to complete the revisions and, hopefully,
positively affect clinical trial access.
The need to meet the standard of care by
offering access to clinical trials has been discussed with Dr. Randy
Petzel, the Undersecretary for Health, the Chiefs of Staff, and the VISN
Chief Medical Officers.
The Oncology Field Advisory Committee
has set as a goal for this year to compose a "How To" document for
conducting clinical trials in the VA. If you are interested in working
on that effort, please contact Dr. Anna Schorer, Chair of the FAC.
An email list has been established as a
means of communicating about VA-related clinical trials. This is
intended to be a forum for sharing of best practices among facilities as
well as discussing availability of trials. Many pharmaceutical
companies and individual investigators are interested in finding VA
facilities that may be interested in opening clinical trials. I will
send any such inquires I receive to this email list and it would be
appropriate for others to do the same.
I strongly recommend that at least one
person from your facility subscribe to this email list. A VA email
address is not required.
To subscribe go to:
http://www.listserv.va.gov/
then Subscriber's Corner
Be sure to check the Junk Folder as the
subscription notices and email from the list may end up there.
Finally, you may be interested to read
the Institute of Medicine's report on the future of the NCI cooperative
groups.
http://www.iom.edu/Reports/2010/A-National-Cancer-Clinical-Trials-System
-for-the-21st-Century-Reinvigorating-the-NCI-Cooperative.aspx
Best regards to all,
Mike
Michael J Kelley, MD
National Program Director for
Oncology/MSS/PCS
Chief, Hematology/Oncology Durham VAMC
Assoc Prof of Medicine, Duke University
Hematology/Oncology (111G)
508 Fulton St.
Durham, NC 27705
919-286-0411 ext 7326
Oncology Sharepoint
http://vaww.medicalsurgical.wss.va.gov/oncology/
<http://vaww.medicalsurgical.wss.va.gov/oncology/>
|
|
|
Questions or comments about this Update may be directed to:
Email:
navref@navref.org
|
Phone: 301-656-5005 |
Fax: 301-656-5008 |
|